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ABSTRACT 
"If you know the enemy and know yourself, you need not fear the result of a 
hundred battles. If you know yourself but not the enemy, for every victory gained 
you will also suffer a defeat" (SunTzu the Art of War, 544-496 BC). Although 
written for the managing of conflicts and winning clear victories, this basic 
guideline can be directly transferred to our battle against apicomplexan parasites 
and how to focus future basic research in order to transfer the gained knowledge 
to a therapeutic intervention stratey. Over the last two decades the establishment 
of several key-technologies, by different groups working on Toxoplasma gondii, 
made this important human pathogen accessible to modern approaches in 
molecular cell biology. In fact more and more researchers get attracted to this 
easy accessible model organism to study specific biological questions, unique to 
apicomplexans. This fascinating, unique biology might provide us with new 
therapeutic options in our battle against apicomplexan parasites by finding its 
Achilles' heel. In this article we argue that in the absence of a powerful high 
throughput technology for the characterisation of essential gene of interests a 
coordinated effort should be undertaken to convert our knowledge of the genome 
into one of the phenome. 
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If one mention "apicomplexan parasites" most people in the world think of 
horrifying diseases like malaria or toxoplasmosis. Although a central aim of 
research should be the rapid development of new drugs and vaccines against 
these pathogens using "traditional" screening methods, many researchers study 
these "bugs" for the sake of science itself. In fact, over the last two decades, 
boosted by the establishment of several key technologies (Meissner et al. 2007b), 
more and more researchers discover apicomplexans as attractive model 
organisms to study specific questions, like plastid biology, secretory pathway, cell 
motility or host pathogen interactions (Gubbels & Striepen 2004, Kim & Weiss 
2004, Frischknecht et al. 2006, Vaishnava & Striepen 2006, Carruthers & 
Boothroyd 2007, Striepen et al. 2007). 
However, the main challenge is to determine on what research should be focused 
in the future. Which questions should be raised and studied specifically in 
apicomplexan parasites, because they are of interest, both for fundamental 
biology and development of future therapies. In consequence, we also need to 
decide which questions can be neglected or postponed, since they have likely 
been answered previously in more accessible model organisms, such as yeast, 
Drosophila, Homo. Alternatively, should we ignore previous findings in other 
organisms and study every gene identified in the genome to characterise the 
phenome of this parasite. This approach would include highly conserved and 
unique genes in the analysis. 
In the later case we need to establish more powerful high throughput 
methodologies that enable us to look at every single gene in an easy and 
effective way. However, in the absence of functional siRNA-methods (Meissner et 
al. 2007b), it is hard to imagine how such an approach is feasible. One alternative 
would be the establishment of a collaborative research network, with the aim to 
characterise every gene of interest (GOI) in a systematic approach, using the 
technologies currently available and sharing the load of work involved. While this 
approach is very work intense and requires considerable resources it would be a 
good investment into the future to generate a library of mutant parasites that is 
accessible to the community and represents a resource for the further study of 
specific questions. At this point it is worth to point out (once again) that in fact 
these approaches were very successful in other model organisms, such as yeast 
[Prophecy: (Fernandez-Ricaud et al. 2007), mouse (Fernandez-Ricaud et al. 
2007) or plants (Edwards & Batley 2004)]. 
In this article we would like to briefly review the current tools available to 
genetically manipulate the parasite to characterise GOIs and discuss if a 
combination of these tools would facilitate a "phenome" approach in Toxoplasma 
gondii and what technologies could be exploited in the future for this effort. We 
would like to discuss how the field could make the next step in molecular biology 
in order to convert our knowledge of the genome to one of the phenome by 
establishing a collaborative network. 
Molecular tools for identification and characterisation of essential genes: 
a slow "one-by-one" approach 
After the first successful transfection of T. gondii 15 years ago (Soldati & 
Boothroyd 1993), several groups continuously established reverse genetic tools 
that allow stable transfection, homologous and non-homologous (random) 
recombination, fluorescent labelling of parasites ectopic regulation of essential 
genes or complementation cloning (Meissner et al. 2007a). During the asexual life 
cycle, T. gondii is haploid, a fact that makes the removal of a gene via 
homologous recombination straight forward. However, in case the GOI is 
essential during the asexual life cycle, the generation of mutant parasites is 
impossible. In order to characterise essential factors in detail, three strategies are 
currently being employed with great success: (i) generation of temperature 
sensitive mutants followed by complementation cloning to identify the mutated 
gene (Gubbels et al. 2008); (ii) employment of a tetracycline inducible (Tet-
inducible) transactivator system (Meissner et al. 2002) and (iii) a recently 
established degradation system (ddFKBP-system) that allows the rapid regulation 
of a protein of interest (Herm-Gotz et al. 2007). However, as mentioned above, 
the absence of a "real" high throughput system, such as siRNA based methods 
(Ullu et al. 2004), is seriously hampering a genome wide approach as performed 
in other eukaryotes. 
The three systems currently employed have obvious advantages and 
disadvantages that need to be taken into consideration before a GOI is attempted 
to be analysed. Although the generation of temperature sensitive mutants 
appears to be relatively straight forward, the isolation of the respective locus 
might be complicated in case several genes have been mutated or the respective 
mutation has a dominant effect. However, with the optimisation of 
complementation technologies (Striepen et al. 2002, Gubbels et al. 2008), this 
technique has been currently demonstrated to be very powerful for the 
identification and isolation of novel essential genes (Gubbels et al. 2008). The 
obvious advantage of this strategy is that hypothetical genes that might 
otherwise be neglected in targeted approaches will be identified with equal 
probability. The Tet-inducible transactivator system is currently the most robust 
method to generate conditional mutants for essential genes in a targeted 
approach and appears to be especially well suited for the characterisation of 
factors involved in invasion and apicoplast biology (Meissner et al. 2002, Mital et 
al. 2005, Huynh & Carruthers 2006, Mazumdar et al. 2006, Kessler et al. 2008, 
Plattner et al. 2008) whereas employment of the system for other essential GOIs 
might result only in weak phenotypes (Fleige et al. 2008) or might not be 
possible at all (unpublished observations). A major advantage of the Tet-inducible 
system is that virtually any GOI can be regulated whereas regulation at the 
protein level using ddFKBP might not work for proteins targeted to the secretory 
system (Herm-Gotz et al. 2007, and unpublished observations). However, apart 
from certain inefficiency problems, the application of the Tet-inducible system is 
very work intense. Three independent stable transfection and selections for clonal 
parasite populations are required, which takes at least three months for a single 
gene and hence is not applicable in a genome wide approach. 
In contrast, the ddFKBP-system is especially well suited for the characterisation of 
essential proteins in a dominant negative approach. Here a single stable 
transfection is sufficient to generate the respective parasite mutant. Other 
advantages of this system are the rapid induction kinetics and the possibility to 
tune the level of protein level simply via adding different amounts of inducer 
(Herm Gotz et al. 2007). 
The generation of parasite mutants using random insertion mutagenesis is 
another promising approach. However, in this approach only non-essential genes 
for tachyzoite growth in vitro can be identified. Hence this strategy has been 
mainly employed to identify genes required for differentiation from tachyzoites to 
bradyzoites (Matrajt et al. 2002, Vanchinathan et al. 2005). In the future, a 
combination of ectopic gene regulation systems with random insertional 
mutagenesis might be possible. In fact, we recently generated a parasite strain 
expressing a regulable Flp-recombinase that should allow temporal control of site-
specific recombination. Our hope is that saturation of the genome with Frt-sites 
via random insertion and subsequent activation of Flp will result in an easy to 
analyse mutant population of parasites (unpublished observations). 
In conclusion, several strategies have been developed by several groups that 
allow characterisation of essential genes. However, so far researchers in the field 
aim to target a specific set of candidate genes. With more and more established 
easy-to-use tools the chance of redundant work on one and the same GOI 
increases. Therefore the next step should be taken: establishment of a phenome-
network that aims to generate parasite mutants for GOI at large scale in order to 
provide a valuable resource for the community. 
A rapid "hand in hand" approach to tackle the phenome 
As summarised above, the generation and phenotypisation of mutants impaired in 
essential steps during the asexual life cycle combined with a complementation 
strategy is a very promising approach and has been successfully applied for a 
forward genetic screen to identify novel essential genes involved in cell cycle 
regulation (Gubbels et al. 2008). Similar strategies for other mutants (i.e., host 
cell invasion) would perfectly complement a targeted approach for promising 
GOIs. In addition, the further optimisation and development of reverse genetic 
tools could lead to more time efficient screening protocols. 
For the characterisation of GOI in a targeted approach a systematic, coordinated 
analysis of the existing databases needs to be performed to generate a priority 
list that includes the most promising factors. For example, a focus on the 
"drugable" genome could be envisioned or the systematic analysis of certain 
unique organelles/pathways/mechanisms like invasion, vesicle trafficking, 
apicoplast biology or host-parasite interactions. Subsequently, conditional gene 
expression systems can be employed to generate and initially analyse mutants for 
the respective GOI in a medium throughput. Given the huge amount of work, this 
effort needs to be efficiently coordinated by several research groups. 
The ddFKBP-system would provide a good starting point for such a systematic 
approach with obvious limitations, since it is a one component system, meaning 
that a single transfection would be sufficient to establish a mutant with a 
regulable, dominant-negative/active copy of the GOI. Therefore, the 
establishment of an efficient medium-throughput approach for the 
characterisation of certain GOIs should be feasible. In fact, we recently generated 
mutants for different classes of proteins as a proof of concept, like GTPases, 
protein-kinase or motor proteins (myosins, dyneins, kinesins). 
Obviously, this approach can not be applied for all GOIs, since minimum 
information about the GOI needs to be available beforehand to predict mutations 
that lead to a trans-dominant version of the GOI. However, in combination with 
proper bioinformatic analysis, an extensive list of GOIs could be assembled that 
contains several promising drug and vaccine candidates that await their future 
validation. 
Currently, the ddFKBP-system allows efficient regulation of cytosolic proteins, 
whereas secretory proteins (especially soluble ones) can not be tackled with this 
system (our unpublished observations). Therefore, we are currently attempting to 
combine the ddFKBP-system with a site-specific recombination system to remove 
a GOI after addition of inducer and hence add temporal control to the system. 
Until this novel tool can be efficiently applied, the Tet-inducible transactivator 
system can be employed to "close the gap", since it has been demonstrated to 
work reliable for several proteins destined for the secretory pathway. 
The next step after generation of a conditional mutant should be the detailed 
characterisation of the respective phenotype. Given the limited output of 
conditional mutants and the work-intensity involved for its establishment in the 
past, the usual approach was to establish and analyse a given mutant irrespective 
of the resulting phenotype. Now that the establishment of mutants can be 
achieved in a more time efficient manner, it gives researchers the freedom to 
concentrate on mutants with expected, surprising and interesting phenotypes, 
whereas others can be stored for later characterisation or made available to the 
community. Therefore, a central phenome database, possibly integrated into 
ToxoDB (www.toxoDB.org) should be established where information about novel 
mutants can be submitted and made available to the field. Similar databases exist 
for other organisms and could be easily adapted 
(http://prophecy.lundberg.gu.se/). The figure shows schematically how such an 
integrated approach could be organised. Briefly mutants are generated in random 
screens (temperature sensitive mutants or random insertional mutagenesis) and 
the respective mutation is identified. In parallel, coordinated bioinformatic 
database mining generates a list of priority candidates that are systematically 
characterised using conditional gene expression systems (ddFKBP or Tet-system). 
Mutants then need to be characterised in a standardised and rapid assays. In our 
opinion, the minimal information that needs to be provided is if the respective 
mutant shows a general growth defect and if this is due to the intracellular 
development of the parasite or due to a defect in host cell invasion. Finally, a 
summary of this information can be entered in an open access database and 
made available to the community (Figure). 
  
 
  
An "easy" start: systematic analysis of factors involved in vesicular 
trafficking 
As mentioned above, the ddFKBP-system is especially well suited to characterise 
essential proteins in a dominant negative approach. For this, a single transfection 
is sufficient in order to generate a mutant parasite strain. However, minimal 
information about the protein is required in order to generate appropriate 
expression constructs that lead to a trans-dominant phenotype. We are currently 
focusing on proteins containing GTPase domains and other P-loop containing 
proteins (i.e. dynamins, motor proteins). The advantage here is that the domain 
architecture of these proteins allows the easy introduction of a single point 
mutation to generate a trans-dominant version of the respective protein. In fact, 
we generated a whole set of mutants for small Rab-GTPases that can be 
efficiently regulated using ddFKBP-system (Herm-Gotz et al. 2007) and in 
preparation. 
Rab proteins represent the largest family of monomeric ras-related GTPases and 
play a crucial role in membrane transport to and from organelles (Grosshans et 
al. 2006). Interestingly, while in higher eukaryotes more then 60 members of this 
family can be identified, apicomplexan parasites possess a reduced set of Rab-
proteins that must be sufficient to organise specific vesicular trafficking in these 
parasites (Langsley et al. 2008, Sheiner & Soldati-Favre 2008). Whereas 
Toxoplasma encodes 14 different Rabs, Plasmodia have 11 and Theileria just nine 
putative genes for Rab proteins. Currently, the role of two Rab-proteins (Rab5A 
and Rab6) has been analysed in more detail in T.gondii, by expressing either 
dominant negative or dominant active versions of the respective Rab (Robibaro et 
al. 2002, Stedman et al. 2003). However, the limitation of expressing trans-
dominant versions of a protein in transient transfections is that the resulting 
phenotype might be non-specific and is in general hard to study in detail. 
Employment of the ddFKBP-system now gives us the chance to generate a clonal 
parasite line expressing each Rab-proteins in a regulated and tuneable manner, 
which results in a population of parasites that behaves identical, as shown for 
Rab1 and Rab11A (Herm-Gotz et al. 2007). Given the reduced core set of 
proteins involved in vesicular trafficking, we are optimistic that this approach will 
allow a systematic dissection of protein trafficking, organellar biogenesis and 
endocytosis in a relatively fast and straight forward approach. In this respect, it 
will be especially interesting to elucidate mechanisms involved in the synthesis of 
specialised secretory organelles and structures that evolved specifically in 
apicomplexan parasites in order to adapt to a parasitic lifestyle a question that is 
of high interest in the light of more general biology but also in order to identify 
and validate drug targets for the future therapeutic intervention. 
Over the past decades, several key-technologies have been developed that allow 
the generation of parasite mutants for GOIs. However, all of these tools have one 
major disadvantage: they are work intense and do not allow a generation of 
mutants in a high throughput approach. However, a coordinated combination of 
the available technologies would allow at least the systematic characterisation of 
a subset of GOIs. Therefore the time has come to coordinate the efforts of 
different groups to reach the next logical goal after the characterisation of the 
genome, transcriptome and proteome: the phenome of T. gondii has come within 
our reach and will cast many new challenges for the next 100 years of research 
on T. gondii. 
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